TipRanks
Advertisement
Advertisement

SE:EQL Stock Latest News

EQL Pharma AGM Confirms Board, Withholds Dividend and Launches New Incentive Plan
Company AnnouncementsEQL Pharma AGM Confirms Board, Withholds Dividend and Launches New Incentive Plan
2M ago
EQL Pharma Licenses UTI Drug Memprex to Pharmacenter in Hungary
PremiumCompany Announcements
EQL Pharma Licenses UTI Drug Memprex to Pharmacenter in Hungary
2M ago
EQL Pharma Hit by Write-Downs and Delays but Holds 15% Sales Growth Outlook
PremiumCompany Announcements
EQL Pharma Hit by Write-Downs and Delays but Holds 15% Sales Growth Outlook
2M ago
Is 7JK a Buy, Before Earnings?
PremiumPre-Earnings
Is 7JK a Buy, Before Earnings?
2M ago
EQL Pharma hires new Chief Supply Chain Officer to support next growth phase
PremiumCompany Announcements
EQL Pharma hires new Chief Supply Chain Officer to support next growth phase
2M ago
EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan
PremiumCompany AnnouncementsEQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan
3M ago
EQL Pharma’s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach
Premium
Company Announcements
EQL Pharma’s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach
3M ago
EQL Pharma Licenses UTI Drug Memprex to Gebro for Spanish Market
Premium
Company Announcements
EQL Pharma Licenses UTI Drug Memprex to Gebro for Spanish Market
3M ago
EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation
PremiumCompany Announcements
EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation
3M ago
EQL Pharma’s Cystohipp Launch Opens New UTI Market in Germany
PremiumCompany Announcements
EQL Pharma’s Cystohipp Launch Opens New UTI Market in Germany
4M ago
EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline
PremiumCompany Announcements
EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline
5M ago
7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
EQL Pharma Seeks New Supply Chain Chief to Bolster Niche Generics Strategy
PremiumCompany AnnouncementsEQL Pharma Seeks New Supply Chain Chief to Bolster Niche Generics Strategy
5M ago
EQL Pharma Sets May 8 Presentation for Year-End 2025/26 Results
Premium
Company Announcements
EQL Pharma Sets May 8 Presentation for Year-End 2025/26 Results
6M ago
EQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption
Premium
Company Announcements
EQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption
6M ago
EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan
PremiumCompany Announcements
EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan
7M ago
EQL Pharma Names Nomination Committee Ahead of 2026 AGM
PremiumCompany Announcements
EQL Pharma Names Nomination Committee Ahead of 2026 AGM
8M ago
EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees
PremiumCompany Announcements
EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees
8M ago
EQL Pharma Posts Record Quarter as European Expansion and Pipeline Drive Growth
PremiumCompany Announcements
EQL Pharma Posts Record Quarter as European Expansion and Pipeline Drive Growth
8M ago
7JK Earnings this Week: How Will it Perform?
PremiumPre-Earnings7JK Earnings this Week: How Will it Perform?
8M ago
EQL Pharma to Present Q3 2025/26 Interim Report in February
Premium
Company Announcements
EQL Pharma to Present Q3 2025/26 Interim Report in February
9M ago
EQL Pharma Calls EGM to Approve New Executive Warrant Incentive Scheme
Premium
Company Announcements
EQL Pharma Calls EGM to Approve New Executive Warrant Incentive Scheme
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >